On May 21, the Federal Appeals Court ruled that the 340B statute doesn’t prohibit drugmakers from placing any conditions on distribution of 340B drugs to covered entities. However, the ruling left open the possibility that more stringent conditions by drugmakers could be illegal. NACHC is analyzing the appeal and its impact on FQHCs. Click here to read the appeal.
